Jaguar Health announced that the board of directors has been established for Magdalena Biosciences, Inc., the joint venture recently formed by Jaguar and Filament Health. Magdalena board members include Jaguar Founder, President, and CEO Lisa Conte, Filament Co-Founder and CEO Benjamin Lightburn, and Jack Wielebinski, Fund Operating Officer, One Small Planet, LLC. Jaguar also announced that Dr. Karen Brunke, Jaguar’s EVP of Corporate and Business Development, has been appointed acting CEO of Magdalena.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on JAGX:
- Jaguar Health to hold an investor webcast
- Jaguar Health appoints Sandra Swain to scientific advisory board
- Jaguar Health, Filament Health form joint venture Magdalena Biosciences
- Jaguar Health provides updates on crofelemer for pediatric SBS, CDD
- Jaguar Health’s Napo sponsors episode of The Gayly Dose podcast